VNDA Financial Statements

Balance sheet, income statement, cash flow, and dividends for Vanda Pharmaceuticals Inc (VNDA).


$279.30M Market Cap.

As of 02/18/2025 5:00 PM ET (MRY) • Disclaimer

VNDA Market Cap. (MRY)


VNDA Shares Outstanding (MRY)


VNDA Assets (MRY)


Total Assets

$656.20M

Total Liabilities

$117.66M

Total Investments

$272.33M

VNDA Income (MRY)


Revenue

$198.77M

Net Income

-$18.90M

Operating Expense

$228.12M

VNDA Cash Flow (MRY)


CF Operations

-$15.76M

CF Investing

-$17.43M

CF Financing

-$155.00K

VNDA Dividends (MRY)


Period

Dividends

Yield %

Growth %

Payout Ratio

Coverage Ratio

2024

$0

0%

0%

0%

-

2023

$0

0%

0%

0%

-

2022

$0

0%

0%

0%

-

2021

$0

0%

0%

0%

-

2020

$0

0%

-

0%

-

VNDA Balance Sheet (MRY)


Metric

2024

2023

2022

2021

Total Assets

$656,204,000 (1.20%)

$648,440,000 (2.24%)

$634,247,000 (6.81%)

$593,792,000 (11.31%)

Assets Current

$438,890,000 (1.37%)

$432,946,000 (-16.63%)

$519,292,000 (8.57%)

$478,301,000 (16.90%)

Assets Non-Current

$217,314,000 (0.84%)

$215,494,000 (87.46%)

$114,955,000 (-0.46%)

$115,491,000 (-7.10%)

Goodwill & Intangible Assets

$114,096,000 (-5.99%)

$121,369,000 (553.75%)

$18,565,000 (-7.55%)

$20,081,000 (-6.86%)

Shareholders Equity

$538,546,000 (-1.17%)

$544,910,000 (3.36%)

$527,198,000 (4.41%)

$504,928,000 (11.40%)

Property Plant & Equipment Net

$12,677,000 (38.70%)

$9,140,000 (-16.70%)

$10,973,000 (-11.40%)

$12,385,000 (-15.14%)

Cash & Equivalents

$102,316,000 (-24.67%)

$135,821,000 (0.59%)

$135,029,000 (159.32%)

$52,071,000 (-14.68%)

Accumulated Other Comprehensive Income

$74,000 (346.67%)

-$30,000 (97.49%)

-$1,193,000 (-581.71%)

-$175,000 (-173.22%)

Deferred Revenue

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Total Investments

$272,327,000 (7.88%)

$252,443,000 (-23.92%)

$331,830,000 (-12.85%)

$380,742,000 (24.14%)

Investments Current

$272,327,000 (7.88%)

$252,443,000 (-23.92%)

$331,830,000 (-12.85%)

$380,742,000 (24.14%)

Investments Non-Current

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Inventory

$10,827,000 (-4.54%)

$11,342,000 (-9.78%)

$12,572,000 (37.07%)

$9,172,000 (15.79%)

Trade & Non-Trade Receivables

$47,101,000 (37.90%)

$34,155,000 (1.92%)

$33,512,000 (3.22%)

$32,467,000 (8.09%)

Trade & Non-Trade Payables

$39,086,000 (1.63%)

$38,460,000 (-15.57%)

$45,551,000 (32.27%)

$34,438,000 (9.30%)

Accumulated Retained Earnings (Deficit)

-$174,292,000 (-12.16%)

-$155,392,000 (1.59%)

-$157,901,000 (3.82%)

-$164,176,000 (16.80%)

Tax Assets

$81,440,000 (8.59%)

$75,000,000 (1.30%)

$74,039,000 (-1.12%)

$74,878,000 (-8.14%)

Tax Liabilities

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Total Debt

$8,090,000 (15.47%)

$7,006,000 (-20.50%)

$8,813,000 (-12.35%)

$10,055,000 (-12.54%)

Debt Current

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Debt Non-Current

$8,090,000 (15.47%)

$7,006,000 (-20.50%)

$8,813,000 (-12.35%)

$10,055,000 (-12.54%)

Total Liabilities

$117,658,000 (13.65%)

$103,530,000 (-3.29%)

$107,049,000 (20.46%)

$88,864,000 (10.82%)

Liabilities Current

$99,981,000 (14.01%)

$87,697,000 (-4.09%)

$91,436,000 (22.87%)

$74,419,000 (12.87%)

Liabilities Non-Current

$17,677,000 (11.65%)

$15,833,000 (1.41%)

$15,613,000 (8.09%)

$14,445,000 (1.34%)

VNDA Income Statement (MRY)


Metric

2024

2023

2022

2021

Revenues

$198,772,000 (3.18%)

$192,640,000 (-24.27%)

$254,382,000 (-5.32%)

$268,682,000 (8.27%)

Cost of Revenue

$11,314,000 (-23.53%)

$14,796,000 (-39.07%)

$24,282,000 (-5.26%)

$25,629,000 (9.69%)

Selling General & Administrative Expense

$146,414,000 (29.70%)

$112,883,000 (-17.29%)

$136,485,000 (10.03%)

$124,047,000 (-11.72%)

Research & Development Expense

$74,431,000 (-3.11%)

$76,823,000 (-10.43%)

$85,770,000 (13.81%)

$75,363,000 (35.60%)

Operating Expenses

$228,118,000 (18.94%)

$191,796,000 (-14.29%)

$223,771,000 (11.39%)

$200,888,000 (1.68%)

Interest Expense

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Income Tax Expense

-$4,021,000 (-204.99%)

$3,830,000 (-23.78%)

$5,025,000 (-45.45%)

$9,212,000 (10.75%)

Net Loss Income from Discontinued Operations

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Consolidated Income

-$18,900,000 (-853.29%)

$2,509,000 (-60.02%)

$6,275,000 (-81.07%)

$33,152,000 (42.06%)

Net Income to Non-Controlling Interests

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Income

-$18,900,000 (-853.29%)

$2,509,000 (-60.02%)

$6,275,000 (-81.07%)

$33,152,000 (42.06%)

Preferred Dividends Income Statement Impact

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Income Common Stock

-$18,900,000 (-853.29%)

$2,509,000 (-60.02%)

$6,275,000 (-81.07%)

$33,152,000 (42.06%)

Weighted Average Shares

$58,149,087 (1.34%)

$57,380,975 (1.63%)

$56,461,877 (1.64%)

$55,548,122 (2.06%)

Weighted Average Shares Diluted

$58,149,087 (1.03%)

$57,557,911 (1.01%)

$56,983,171 (0.11%)

$56,921,836 (3.14%)

Earning Before Interest & Taxes (EBIT)

-$22,921,000 (-461.59%)

$6,339,000 (-43.90%)

$11,300,000 (-73.33%)

$42,364,000 (33.83%)

Gross Profit

$187,458,000 (5.41%)

$177,844,000 (-22.71%)

$230,100,000 (-5.33%)

$243,053,000 (8.12%)

Operating Income

-$40,660,000 (-191.43%)

-$13,952,000 (-320.45%)

$6,329,000 (-84.99%)

$42,165,000 (54.80%)

VNDA Cash Flow Statement (MRY)


Metric

2024

2023

2022

2021

Net Cash Flow from Investing

-$17,430,000 (-44.58%)

-$12,056,000 (-124.15%)

$49,925,000 (165.09%)

-$76,696,000 (-84.81%)

Net Cash Flow from Financing

-$155,000 (0%)

$0 (0%)

$734,000 (-79.32%)

$3,550,000 (-36.99%)

Net Cash Flow from Operations

-$15,757,000 (-223.09%)

$12,801,000 (-59.98%)

$31,984,000 (-50.19%)

$64,214,000 (24.03%)

Net Cash Flow / Change in Cash & Cash Equivalents

-$33,505,000 (-4330.43%)

$792,000 (-99.04%)

$82,908,000 (1018.85%)

-$9,023,000 (-156.52%)

Net Cash Flow - Business Acquisitions and Disposals

-$4,229,000 (95.80%)

-$100,665,000 (0%)

$0 (0%)

$0 (0%)

Net Cash Flow - Investment Acquisitions and Disposals

-$12,711,000 (-114.28%)

$88,992,000 (75.86%)

$50,604,000 (166.46%)

-$76,144,000 (-91.78%)

Capital Expenditure

-$490,000 (-27.94%)

-$383,000 (43.59%)

-$679,000 (-23.01%)

-$552,000 (69.25%)

Issuance (Repayment) of Debt Securities

-$155,000 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Issuance (Purchase) of Equity Shares

$0 (0%)

$0 (0%)

$734,000 (-79.32%)

$3,550,000 (-36.99%)

Payment of Dividends & Other Cash Distributions

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Effect of Exchange Rate Changes on Cash

-$163,000 (-446.81%)

$47,000 (-82.26%)

$265,000 (391.21%)

-$91,000 (-271.70%)

Share Based Compensation

$12,432,000 (-11.45%)

$14,040,000 (-13.75%)

$16,279,000 (5.89%)

$15,374,000 (15.07%)

Depreciation Amortization & Accretion

$8,132,000 (170.17%)

$3,010,000 (10.14%)

$2,733,000 (-3.80%)

$2,841,000 (-0.80%)

VNDA Financial Metrics (MRY)


Metric

2024

2023

2022

2021

Gross Margin

94.30% (2.17%)

92.30% (1.99%)

90.50% (0.00%)

90.50% (-0.11%)

Profit Margin

-9.50% (-830.77%)

1.30% (-48.00%)

2.50% (-79.67%)

12.30% (30.85%)

EBITDA Margin

-7.40% (-251.02%)

4.90% (-10.91%)

5.50% (-67.26%)

16.80% (20.86%)

Return on Average Equity (ROAE)

-3.50% (-800.00%)

0.50% (-58.33%)

1.20% (-82.35%)

6.80% (25.93%)

Return on Average Assets (ROAA)

-2.90% (-825.00%)

0.40% (-60.00%)

1.00% (-82.76%)

5.80% (26.09%)

Return on Sales (ROS)

-11.50% (-448.48%)

3.30% (-25.00%)

4.40% (-72.15%)

15.80% (23.44%)

Return on Invested Capital (ROIC)

-6.80% (-440.00%)

2.00% (-23.08%)

2.60% (-73.47%)

9.80% (13.95%)

Dividend Yield

0% (0%)

0% (0%)

0% (0%)

0% (0%)

Price to Earnings Ratio (P/E)

-14.52 (-113.76%)

105.5 (57.04%)

67.18 (156.91%)

26.15 (-14.43%)

Price to Sales Ratio (P/S)

1.4 (11.46%)

1.26 (-23.35%)

1.64 (-49.45%)

3.24 (12.56%)

Price to Book Ratio (P/B)

0.52 (16.37%)

0.45 (-43.76%)

0.79 (-54.19%)

1.73 (9.21%)

Debt to Equity Ratio (D/E)

0.22 (14.74%)

0.19 (-6.40%)

0.2 (15.34%)

0.18 (-0.56%)

Earnings Per Share (EPS)

-0.33 (-925.00%)

0.04 (-63.64%)

0.11 (-81.67%)

0.6 (39.53%)

Sales Per Share (SPS)

3.42 (1.82%)

3.36 (-25.48%)

4.5 (-6.86%)

4.84 (6.07%)

Free Cash Flow Per Share (FCFPS)

-0.28 (-229.17%)

0.22 (-61.01%)

0.55 (-51.66%)

1.15 (24.84%)

Book Value Per Share (BVPS)

9.26 (-2.47%)

9.5 (1.70%)

9.34 (2.72%)

9.09 (9.15%)

Tangible Assets Book Value Per Share (TABVPS)

9.32 (1.50%)

9.19 (-15.76%)

10.9 (5.58%)

10.33 (9.81%)

Enterprise Value Over EBIT (EV/EBIT)

-8 (-172.73%)

11 (-66.67%)

33 (65.00%)

20 (-4.76%)

Enterprise Value Over EBITDA (EV/EBITDA)

-12.46 (-273.70%)

7.17 (-73.35%)

26.92 (45.88%)

18.45 (-5.39%)

Asset Turnover

0.3 (2.01%)

0.3 (-27.43%)

0.41 (-12.34%)

0.47 (-3.29%)

Current Ratio

4.39 (-11.08%)

4.94 (-13.07%)

5.68 (-11.64%)

6.43 (3.58%)

Dividends

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Free Cash Flow (FCF)

-$16,247,000 (-230.83%)

$12,418,000 (-60.33%)

$31,305,000 (-50.83%)

$63,662,000 (27.37%)

Enterprise Value (EV)

$184,285,010 (174.76%)

$67,071,036 (-82.24%)

$377,706,455 (-54.71%)

$834,059,889 (23.89%)

Earnings Before Tax (EBT)

-$22,921,000 (-461.59%)

$6,339,000 (-43.90%)

$11,300,000 (-73.33%)

$42,364,000 (33.83%)

Earnings Before Interest Taxes & Depreciation Amortization (EBITDA)

-$14,789,000 (-258.19%)

$9,349,000 (-33.38%)

$14,033,000 (-68.96%)

$45,205,000 (30.96%)

Invested Capital

$347,901,000 (12.02%)

$310,559,000 (-21.98%)

$398,030,000 (-12.96%)

$457,276,000 (15.35%)

Working Capital

$338,909,000 (-1.84%)

$345,249,000 (-19.31%)

$427,856,000 (5.94%)

$403,882,000 (17.68%)

Tangible Asset Value

$542,108,000 (2.85%)

$527,071,000 (-14.39%)

$615,682,000 (7.32%)

$573,711,000 (12.08%)

Market Capitalization

$279,296,010 (15.04%)

$242,785,036 (-41.95%)

$418,200,455 (-52.16%)

$874,124,889 (21.63%)

Average Equity

$541,570,000 (0.12%)

$540,911,750 (5.36%)

$513,381,750 (5.47%)

$486,774,000 (11.79%)

Average Assets

$651,343,000 (1.13%)

$644,064,750 (4.36%)

$617,173,750 (8.07%)

$571,098,750 (11.73%)

Invested Capital Average

$339,361,250 (8.13%)

$313,835,250 (-28.51%)

$439,010,750 (1.38%)

$433,019,000 (17.30%)

Shares

58,308,144 (1.35%)

57,531,999 (1.66%)

56,590,048 (1.58%)

55,712,230 (1.87%)